Related Experiment Video
Updated: Mar 31, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Early definite stent thrombosis with everolimus-eluting stents
Ryo Naito1, Katsumi Miyauchi1, Hirokazu Konishi1
1Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine Tokyo, Japan.
Insights
Stent thrombosis (ST) is a severe complication after coronary intervention. This case highlights how limited blood flow and antiplatelet resistance can cause ST, even with advanced stents.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
- Stent thrombosis (ST) is a rare but serious complication following PCI.
- Everolimus-eluting stents (EES) are designed to minimize ST risk.
Observation:
- A case of ST occurred despite the use of an EES.
- The patient presented with factors contributing to increased ST risk.
- Limited coronary flow and resistance to antiplatelet agents were identified as key issues.
Findings:
- The combination of limited coronary flow and antiplatelet resistance significantly elevates ST risk.
- Even modern stents like EES are not entirely immune to ST under specific adverse conditions.
- This case underscores the multifactorial nature of stent thrombosis.
Implications:
- Clinicians must consider combined risk factors for ST, including flow limitations and drug resistance.
- Further research may be needed to optimize antiplatelet strategies in high-risk PCI patients.
- Understanding these factors is crucial for improving long-term outcomes after stenting.
Abstract:
Stent thrombosis (ST) is a serious complication of percutaneous coronary intervention. Several factors are associated with ST, and combination of these factors increase the risk, even in everolimus-eluting stents, which have low risk of ST. We experienced a case of ST caused by limited coronary flow and resistance to antiplatelet agent.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
09:46Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
Published on: September 14, 2009